Ben George, MD

Publications

• Efficacy and Safety of Trifluridine/Tipiracil-Containing Combinations in Colorectal Cancer and Other Advanced Solid Tumors: A Systematic Review.

  (Shitara K, Falcone A, Fakih MG, George B, Sundar R, Ranjan S, Van Cutsem E.) Oncologist. 2024 Feb 16 PMID: 38366864 02/17/2024

• Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma.

  (George B, Kudryashova O, Kravets A, Thalji S, Malarkannan S, Kurzrock R, Chernyavskaya E, Gusakova M, Kravchenko D, Tychinin D, Savin E, Alekseeva L, Butusova A, Bagaev A, Shin N, Brown JH, Sethi I, Wang D, Taylor B, McFall T, Kamgar M, Hall WA, Erickson B, Christians KK, Evans DB, Tsai S.) Gastroenterology. 2024 Jan 25 PMID: 38280684 SCOPUS ID: 2-s2.0-85188891214 01/28/2024

• Characterization of an oligometastatic state in patients with metastatic pancreatic adenocarcinoma undergoing systemic chemotherapy.

  (de Ortiz de Choudens S, Visotcky A, Banerjee A, Aldakkak M, Tsai S, Evans DB, Christians KK, Clarke CN, George B, Shreenivas A, Kamgar M, Chakrabarti S, Dua KS, Khan AH, Madhavan S, Erickson BA, Hall WA.) Cancer Med. 2023 Dec 22;13(1) PMID: 38140796 PMCID: PMC10807686 SCOPUS ID: 2-s2.0-85180644976 12/23/2023

• Biliary Adverse Events During Neoadjuvant Therapy for Pancreatic Cancer.

  (Thalji SZ, Fernando D, Dua KS, Madhavan S, Chisholm P, Smith ZL, Aldakkak M, Christians KK, Clarke CN, George B, Kamgar M, Erickson BA, Hall WA, Evans DB, Tsai S.) Ann Surg. 2023 Dec 01;278(6):e1224-e1231 PMID: 37078282 SCOPUS ID: 2-s2.0-85176508848 04/20/2023

• ALK fusions in the pan-cancer setting: another tumor-agnostic target?

  (Shreenivas A, Janku F, Gouda MA, Chen HZ, George B, Kato S, Kurzrock R.) NPJ Precis Oncol. 2023 Sep 29;7(1):101 PMID: 37773318 PMCID: PMC10542332 SCOPUS ID: 2-s2.0-85173930134 09/29/2023

• Effects of prior therapies on outcomes with trifluridine/tipiracil in patients with metastatic gastric/gastroesophageal junction cancer in a randomized phase III trial (TAGS).

  (Shitara K, George B, Taieb J, Sundar R, Fakih MG, Makris L, Benhadji KA, Ghidini M.) J Cancer Res Clin Oncol. 2023 Sep;149(11):9361-9374 PMID: 37213030 PMCID: PMC10374776 05/22/2023

• Neoadjuvant chemotherapy for pancreatic cancer: Quality over quantity.

  (Thalji SZ, Aldakkak M, Christians KK, Clarke CN, George B, Kamgar M, Erickson BA, Hall WA, Chisholm P, Kulkarni N, Doucette S, Evans DB, Tsai S.) J Surg Oncol. 2023 Jul;128(1):41-50 PMID: 36960919 SCOPUS ID: 2-s2.0-85152449940 03/25/2023

• A Paradigm Shift in Primary Liver Cancer Therapy Utilizing Genomics, Molecular Biomarkers, and Artificial Intelligence.

  (Moroney J, Trivella J, George B, White SB.) Cancers (Basel). 2023 May 17;15(10) PMID: 37345129 PMCID: PMC10216313 SCOPUS ID: 2-s2.0-85160713805 06/22/2023

• ASO Visual Abstract: CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/ nab-Paclitaxel for Patients with Operable Pancreatic Cancer.

  (Thalji SZ, Kamgar M, George B, Aldakkak M, Christians KK, Clarke CN, Erickson BA, Hall WA, Tolat PP, Smith ZL, Evans DB, Tsai S.) Ann Surg Oncol. 2023 May;30(5):3022 PMID: 36877324 SCOPUS ID: 2-s2.0-85152164746 03/07/2023

• CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer.

  (Thalji SZ, Kamgar M, George B, Aldakkak M, Christians KK, Clarke CN, Erickson BA, Hall WA, Tolat PP, Smith ZL, Evans DB, Tsai S.) Ann Surg Oncol. 2023 May;30(5):3013-3021 PMID: 36788189 SCOPUS ID: 2-s2.0-85147934173 02/15/2023

• Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal Cancer.

  (Matoska T, Banerjee A, Shreenivas A, Jurkowski L, Shukla ME, Gore EM, Linsky P, Gasparri M, George B, Johnstone C, Johnstone D, Puckett LL.) Cancers (Basel). 2023 Apr 28;15(9) PMID: 37173988 PMCID: PMC10177457 SCOPUS ID: 2-s2.0-85159164697 05/13/2023

• Comprehensive genomic profiling: Does timing matter?

  (Thapa B, Ahmed G, Szabo A, Kamgar M, Kilari D, Mehdi M, Menon S, Daniel S, Thompson J, Thomas J, George B.) Front Oncol. 2023;13:1025367 PMID: 36865796 PMCID: PMC9971445 03/04/2023